Safety of Cetirizine, Paracetamol, Cadi OR, and PAN During Breastfeeding
All four medications can be used during breastfeeding with appropriate precautions: cetirizine and paracetamol are safe, pantoprazole (PAN) is compatible with minimal milk transfer, but the ofloxacin-ornidazole combination (Cadi OR) should be reserved for situations where benefits clearly outweigh risks due to limited safety data on ornidazole during lactation.
Cetirizine (Antihistamine)
Cetirizine is safe for breastfeeding mothers. The FDA label states it is "not recommended" during breastfeeding 1, but this conservative labeling contradicts extensive clinical evidence. Second-generation antihistamines like cetirizine demonstrate a favorable safety profile based on data from more than 186,000 exposures, with the relative infant dose remaining below the 5% safety threshold 2. Multiple studies confirm that all antihistamines are considered safe during breastfeeding, as minimal amounts are excreted in breast milk and would not cause adverse effects in nursing infants 3. Recent systematic reviews covering 1.2 million pregnancies found no significant associations with adverse outcomes 2.
Paracetamol (Acetaminophen)
Paracetamol is unequivocally safe during breastfeeding and should be regarded as the first-line analgesic 4, 5. It is considered compatible with breastfeeding across all major safety databases 6. The drug transfers into milk in minimal amounts, and the relative infant dose remains well below safety thresholds. Short-term and long-term use are both acceptable 7. Among analgesics commonly used in emergency settings, paracetamol poses no restrictions for breastfeeding mothers 6.
PAN (Pantoprazole - Proton Pump Inhibitor)
Pantoprazole is compatible with breastfeeding based on FDA data showing minimal milk transfer. In a documented case, a mother receiving 40 mg oral pantoprazole had detectable milk levels only at 2 hours (36 mcg/L) and 4 hours (24 mcg/L) post-dose, with a milk-to-plasma ratio of 0.022. The relative infant dose was only 0.14% of the weight-adjusted maternal dose—far below the 10% safety threshold 8. No adverse events were reported in the breastfed infant 8. The drug was undetectable in milk at 6,8, and 24 hours after dosing, indicating rapid clearance.
Cadi OR (Ofloxacin-Ornidazole Combination)
This combination requires careful consideration:
Ofloxacin (fluoroquinolone): While the 2026 anesthesia guidelines note that fluoroquinolones "should not be administered as first-line treatment, but if they are indicated, breast feeding should not be interrupted because the risk of adverse effects is low and the risks are justified" 9. Short courses of antibiotics are commonly used perioperatively with no evidence of harmful effects in breastfeeding patients 9.
Ornidazole: This is the limiting factor. While metronidazole (a related nitroimidazole) at low-end dosages is considered appropriate for lactating women 4, specific data on ornidazole during lactation is limited.
Use this combination only when clearly indicated and no safer alternatives exist. If prescribed, use the shortest effective course and monitor the infant for potential effects (diarrhea, candidiasis, irritability).
Clinical Algorithm for Decision-Making
- Paracetamol: Use without restriction as first-line analgesic
- Cetirizine: Use without restriction for allergic symptoms
- Pantoprazole: Use when indicated; time feeding to avoid the 2-4 hour post-dose window if concerned, though risk is minimal
- Ofloxacin-Ornidazole: Reserve for bacterial infections where benefits outweigh theoretical risks; prefer alternatives if available; use shortest effective course
Important Caveats
- The relative infant dose below 10% is generally considered safe; all these medications fall well below this threshold (cetirizine <5%, paracetamol <10%, pantoprazole 0.14%) 2, 7
- Avoid recommending "pump and dump" for these medications—this practice is rarely necessary and the majority of medications used in acute settings are compatible with breastfeeding 6
- Monitor infants for any unusual symptoms, though adverse effects are unlikely with these agents
- Timing of doses to avoid peak milk concentrations can further minimize infant exposure if desired, though this is not necessary for these medications 5